Condition
Shock,Hemorrhagic
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Completed1
Not Yet Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07530653Not Yet Recruiting
Delayed Fluids in Hemorrhagic Shock Due to Severe Injuries.
NCT02872428Phase 1TerminatedPrimary
A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)
NCT01951560Phase 1CompletedPrimary
A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1)
Showing all 3 trials